therapy of lung cancer

Clinical Value of Fibrinogen in Diagnosis and Therapy of Lung Cancer

血浆纤维蛋白原在肺癌诊治中的临床价值

Epidermal growth factor receptor family and molecular targeting therapy of lung cancer

上皮生长因子受体家族与肺癌的分子靶向治疗

Author reviews the application progress on intervenient therapy of lung cancer .

非小细胞肺癌的治疗现仅就各种介入治疗方法临床应用进展作一探讨。

Advances in research on the diagnosis and therapy of lung cancer with bone metastases

肺癌骨转移诊治的研究进展

Application progress on intervenient therapy of lung cancer

肺癌介入治疗的应用进展

Gene Therapy of Lung Cancer

肺癌的基因治疗

At present , the main therapy of lung cancer is surgery , combined with chemotherapy and radiotherapy .

目前的综合治疗措施仍是以手术为主，化疗、放疗为辅。

To improve lung cancer patients ' viability , the earliest diagnosis and therapy of lung cancer is essential .

为了提高肺癌患者的生存率，肺癌的早期诊断与治疗是关键。

RNA interference has been widely used in gene therapy of lung cancer , and has a significant anticancer effect .

RNA干扰已经广泛应用于肺癌的基因治疗，发挥其明显的抗癌作用。

Experimental Study of Cytotoxic T Cells in Combination with PD-L1 mAb in Immunological Therapy of Lung Cancer

细胞毒性T细胞联合PD-L1单抗对肺癌免疫治疗的实验研究

Construction of eukaryotic expression vector containing HSV / TK double suicide genes for targeted therapy of lung cancer

靶向治疗肺癌双自杀基因HSV-TK/CD真核表达载体的构建

The results lay the fundations of functional gene transfer to lung cancer cells and further to the gene therapy of lung cancer .

本实验为阳离子脂质体介导肺癌细胞功能性基因的转移及进一步的肺癌基因治疗打下了基础。

The epidermal growth factor receptor kinase inhibitors ( EGFR-TKI ) play an important role in molecular target therapy of lung cancer .

以表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）为基础的分子靶向药物治疗在肺癌的治疗中发挥着重要作用，成为国内外研究的热点。

The early diagnosis and therapy of lung cancer have improved obviously with the deep study , but the survival rates of five years did not raised significantly .

经过多年的研究和治疗，其早期诊断水平及治疗方法有了明显的进步，但五年生存率仍没有明显的提高。

Besides the traditional treatment , such as operation , radiotherapy and chemotherapeutics , molecular targeting therapy of lung cancer has been developed rapidly in recent years , but it is still the second-line treatment to lung cancer .

除了手术、放疗及传统化疗药物之外，更多研究开始关注于分子靶向药物的开发，但由于这些药物疗效的不稳定性，般仅作为肺癌治疗的二线药物。

To Further evaluate the blood supply of lung cancer using multislice CT angiography of pulmonary and bronchial artery ( PA-MSCTA ; BA-MSCTA ), and thereby provide some implication for interventional therapy of lung cancer .

目的通过支气管动脉和肺动脉多层CT血管造影的方法（BA-MSCTA，PA-MSCTA），进一步研究肺癌血供，为肺癌介入治疗提供指导。

Controversy on Target Therapy of Non-small Cell Lung Cancer

非小细胞肺癌靶向药物治疗争论热点

Objective Analysis prognostic factors related to efficacy and life span of combined therapy of lung metastatic breast cancer .

目的：分析乳腺癌肺转移综合治疗的疗效及影响生存的预后因素。

EGFR tyrosine kinase inhibitor is an investigative hot spot in targeted therapy of non-small cell lung cancer ( NSCLC ) .

EGFR靶向抑制剂，是目前NSCLC靶向治疗的研究热点之一。

The gene therapy of Small cell lung cancer mainly focuses on how to interdict the way of metastasis , so it is very urgent to screen out the correlative gene of metastasis .

小细胞肺癌的基因治疗主要应着眼于阻断转移途径的研究，所以迫切需要筛选出更多的小细胞肺癌的转移相关基因。

Aim To observe the effect of direct current ( DC ) therapy on apoptosis of lung cancer cells and study the inducement and mechanism of small DC electric field in the apoptosis of lung cancer cells .

目的观察应用直流电疗法对肺癌细胞凋亡的影响，研究直流小电场对于肺癌细胞凋亡的诱导作用及其可能机制。

Gemcitabine is a cell cycle specific anticancer agent that are effective for therapy of non-small cell lung cancer ( NSCLC ), breast cancer , ovarian cancer and pancreatic carcinoma and other solid cancers .

吉西他滨是一种周期特异性抗代谢药物，临床主要用于非小细胞肺癌、胰腺癌、膀胱癌、乳腺癌及其他实体肿瘤的治疗。

The experience of microtubular bronchial artery interventional therapy of 22 cases of lung cancer

微导管支气管动脉介入治疗肺癌22例体会

Multimodality therapy of late stage lung Cang cancer

晚期支气管肺癌多学科治疗方案的研究

Objective : To evaluate the best treatment method by retrospective analysis on therapy for 138 cases of lung cancer complicated with superior vena cava syndrome .

目的：对肺癌合并上腔静脉综合征治疗方式进行回顾性分析，以探讨最佳治疗途径。

It would be a new method of targeted therapy in lymphatic metastasis of lung cancer to target cyclooxygenase-2 、 VEGF-C / VEGFR-3 .

环氧化酶2、血管内皮生长因子C/血管内皮生长因子受体3有望成为肺癌淋巴管转移靶向治疗的新靶点。

The recent advances in the research and the application of chemotherapy in multimodality therapy of non small cell lung cancer ( NSCLC ) are reviewed and evaluated .

就近年来非小细胞肺癌（NSCLC）化学治疗研究和应用的进展，进行综述和评述。